{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:10:41Z","timestamp":1790194241733,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Naval Medical University","award":["No. 2022MS026"],"award-info":[{"award-number":["No. 2022MS026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pancreatic cancer (PC) remains one of the most lethal malignancies with unfavorable prognosis globally. Bioinformatics analysis predicted that SEPP1 was low expressed in PC and related to tumor immune microenvironment, but its biological function was still unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>PC xenograft and liver metastasis mouse models, as well as PC cell-MDSCs co-culture system, were established for in vivo and in vitro studies, respectively. The expression and localization of key molecules were detected by qRT-PCR, western blot, immunohistochemistry and immunofluorescence. Flow cytometry was employed to assess the abundance of immune cells and cell apoptosis. The interactions among KAT8, SEPP1 and LRP8 were detected by co-IP. Cell viability, migration and invasion were monitored by CCK-8 and transwell assays.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>SEPP1 was downregulated in pancreatic tumors, and it was positively correlated with the abundance of CD8<jats:sup>+<\/jats:sup> T cells. In vivo overexpression of SEPP1 impaired PC tumor growth and liver metastasis via modulating the abundance of CD8<jats:sup>+<\/jats:sup> T cell and MDSCs. KAT8 upregulated SEPP1 transcription and protein level via catalyzing the acetylation at K247\/249 on SEPP1, and SEPP1 impaired MDSCs survival via its receptor LRP8, thus regulating CD8<jats:sup>+<\/jats:sup> T cell-mediated immune responses in PC. In vivo studies further revealed that SEPP1 recombinant protein enhanced the efficacy of anti-PD-1 therapy in PC xenograft mouse model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>KAT8 catalyzed the acetylation of SEPP1 at K247\/249 and modulated the activity of CD8<jats:sup>+<\/jats:sup> T cells via LRP8 to promote anti-tumor immunity in PC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13578-025-01356-3","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:17:31Z","timestamp":1739978251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["KAT8 catalyzes the acetylation of SEPP1 at lysine 247\/249 and modulates the activity of CD8+ T cells via LRP8 to promote anti-tumor immunity in pancreatic cancer"],"prefix":"10.1186","volume":"15","author":[{"given":"Zhongfei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbao","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"issue":"10242","key":"1356_CR1","first-page":"2008","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, et al. Pancreat cancer Lancet. 2020;395(10242):2008\u201320.","journal-title":"Pancreat cancer Lancet"},{"issue":"7","key":"1356_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18(7):493\u2013502.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"1356_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ags3.12225","volume":"3","author":"T Murakami","year":"2019","unstructured":"Murakami T, et al. Role of the tumor microenvironment in pancreatic cancer. Ann Gastroenterol Surg. 2019;3(2):130\u20137.","journal-title":"Ann Gastroenterol Surg"},{"issue":"1","key":"1356_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2008.09.037","volume":"279","author":"CE Clark","year":"2009","unstructured":"Clark CE, Beatty GL, Vonderheide RH. Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer. Cancer Lett. 2009;279(1):1\u20137.","journal-title":"Cancer Lett"},{"issue":"1","key":"1356_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12957-022-02549-7","volume":"20","author":"X Zhang","year":"2022","unstructured":"Zhang X, et al. Clinical benefits of PD-1\/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis. World J Surg Oncol. 2022;20(1):93.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"1356_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.canlet.2015.12.020","volume":"381","author":"K Foley","year":"2016","unstructured":"Foley K, et al. Current progress in immunotherapy for pancreatic cancer. Cancer Lett. 2016;381(1):244\u201351.","journal-title":"Cancer Lett"},{"issue":"8\u20139","key":"1356_CR7","first-page":"1201","volume":"379","author":"GE Arteel","year":"1998","unstructured":"Arteel GE, et al. Protection by selenoprotein P in human plasma against peroxynitrite-mediated oxidation and nitration. Biol Chem. 1998;379(8\u20139):1201\u20135.","journal-title":"Biol Chem"},{"issue":"22","key":"1356_CR8","doi-asserted-by":"publisher","first-page":"5746","DOI":"10.1046\/j.1432-1033.2002.03298.x","volume":"269","author":"Y Saito","year":"2002","unstructured":"Saito Y, Takahashi K. Characterization of selenoprotein P as a selenium supply protein. Eur J Biochem. 2002;269(22):5746\u201351.","journal-title":"Eur J Biochem"},{"key":"1356_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev.nutr.24.012003.132120","volume":"25","author":"RF Burk","year":"2005","unstructured":"Burk RF, Hill KE. Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr. 2005;25:215\u201335.","journal-title":"Annu Rev Nutr"},{"key":"1356_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.acr.2017.08.002","volume":"136","author":"SP Short","year":"2017","unstructured":"Short SP, Williams CS. Selenoproteins in Tumorigenesis and Cancer progression. Adv Cancer Res. 2017;136:49\u201383.","journal-title":"Adv Cancer Res"},{"issue":"1","key":"1356_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1207\/s15327914nc4801_2","volume":"48","author":"OH Al-Taie","year":"2004","unstructured":"Al-Taie OH, et al. Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis. Nutr Cancer. 2004;48(1):6\u201314.","journal-title":"Nutr Cancer"},{"issue":"8","key":"1356_CR12","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/pros.21298","volume":"71","author":"O Gonzalez-Moreno","year":"2011","unstructured":"Gonzalez-Moreno O, et al. Selenoprotein-P is down-regulated in prostate cancer, which results in lack of protection against oxidative damage. Prostate. 2011;71(8):824\u201334.","journal-title":"Prostate"},{"issue":"2","key":"1356_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.canlet.2007.10.019","volume":"259","author":"Y Murawaki","year":"2008","unstructured":"Murawaki Y, et al. Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett. 2008;259(2):218\u201330.","journal-title":"Cancer Lett"},{"issue":"1","key":"1356_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/147323000903700120","volume":"37","author":"Q Wang","year":"2009","unstructured":"Wang Q, et al. Tissue microarray assessment of selenoprotein P expression in gastric adenocarcinoma. J Int Med Res. 2009;37(1):169\u201374.","journal-title":"J Int Med Res"},{"issue":"7","key":"1356_CR15","doi-asserted-by":"publisher","first-page":"e0236491","DOI":"10.1371\/journal.pone.0236491","volume":"15","author":"J Wang","year":"2020","unstructured":"Wang J, et al. Selenoprotein P inhibits cell proliferation and ROX production in HCC cells. PLoS ONE. 2020;15(7):e0236491.","journal-title":"PLoS ONE"},{"issue":"23","key":"1356_CR16","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1523\/JNEUROSCI.1153-07.2007","volume":"27","author":"RF Burk","year":"2007","unstructured":"Burk RF, et al. Deletion of apolipoprotein E receptor-2 in mice lowers brain selenium and causes severe neurological dysfunction and death when a low-selenium diet is fed. J Neurosci. 2007;27(23):6207\u201311.","journal-title":"J Neurosci"},{"issue":"16","key":"1356_CR17","doi-asserted-by":"publisher","first-page":"12290","DOI":"10.1074\/jbc.M611403200","volume":"282","author":"GE Olson","year":"2007","unstructured":"Olson GE, et al. Apolipoprotein E receptor-2 (ApoER2) mediates selenium uptake from selenoprotein P by the mouse testis. J Biol Chem. 2007;282(16):12290\u20137.","journal-title":"J Biol Chem"},{"issue":"4","key":"1356_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.cell.2017.12.026","volume":"172","author":"MF Tavazoie","year":"2018","unstructured":"Tavazoie MF, et al. LXR\/ApoE activation restricts Innate Immune suppression in Cancer. Cell. 2018;172(4):825\u2013e84018.","journal-title":"Cell"},{"issue":"2","key":"1356_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1139\/bcb-2018-0230","volume":"98","author":"S Du","year":"2020","unstructured":"Du S, et al. Apolipoprotein E2 modulates cell cycle function to promote proliferation in pancreatic cancer cells via regulation of the c-Myc-p21(Waf1) signalling pathway. Biochem Cell Biol. 2020;98(2):191\u2013202.","journal-title":"Biochem Cell Biol"},{"key":"1356_CR20","doi-asserted-by":"crossref","unstructured":"Zhang Y et al. Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer. J Exp Med. 2020;217(12).","DOI":"10.1084\/jem.20190354"},{"key":"1356_CR21","doi-asserted-by":"crossref","unstructured":"Zhang X et al. Combination cancer immunotherapy targeting TNFR2 and PD-1\/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors. J Immunother Cancer. 2022;10(3).","DOI":"10.1136\/jitc-2021-003982"},{"issue":"4","key":"1356_CR22","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1053\/j.gastro.2005.06.056","volume":"129","author":"D Saur","year":"2005","unstructured":"Saur D, et al. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology. 2005;129(4):1237\u201350.","journal-title":"Gastroenterology"},{"key":"1356_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.canlet.2017.08.006","volume":"407","author":"M Feng","year":"2017","unstructured":"Feng M, et al. PD-1\/PD-L1 and immunotherapy for pancreatic cancer. Cancer Lett. 2017;407:57\u201365.","journal-title":"Cancer Lett"},{"issue":"2","key":"1356_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ijc.20304","volume":"112","author":"S Maehara","year":"2004","unstructured":"Maehara S, et al. Selenoprotein P, as a predictor for evaluating gemcitabine resistance in human pancreatic cancer cells. Int J Cancer. 2004;112(2):184\u20139.","journal-title":"Int J Cancer"},{"issue":"46","key":"1356_CR25","doi-asserted-by":"publisher","first-page":"7956","DOI":"10.3748\/wjg.v27.i46.7956","volume":"27","author":"MR Goulart","year":"2021","unstructured":"Goulart MR, et al. T cells in pancreatic cancer stroma. World J Gastroenterol. 2021;27(46):7956\u201368.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1356_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, et al. The nature of myeloid-derived suppressor cells in the Tumor Microenvironment. Trends Immunol. 2016;37(3):208\u201320.","journal-title":"Trends Immunol"},{"key":"1356_CR27","doi-asserted-by":"crossref","unstructured":"Huber M et al. The Immune Microenvironment in Pancreatic Cancer. Int J Mol Sci. 2020;21(19).","DOI":"10.3390\/ijms21197307"},{"issue":"10","key":"1356_CR28","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.21037\/jtd-22-1000","volume":"14","author":"W Wang","year":"2022","unstructured":"Wang W, et al. Histone acetylation modification regulator-mediated tumor microenvironment infiltration characteristics and prognostic model of lung adenocarcinoma patients. J Thorac Dis. 2022;14(10):3886\u2013902.","journal-title":"J Thorac Dis"},{"key":"1356_CR29","doi-asserted-by":"publisher","first-page":"761046","DOI":"10.3389\/fimmu.2022.761046","volume":"13","author":"Y Xu","year":"2022","unstructured":"Xu Y, et al. Histone Acetylation Regulator-mediated acetylation patterns define Tumor Malignant pathways and Tumor Microenvironment in Hepatocellular Carcinoma. Front Immunol. 2022;13:761046.","journal-title":"Front Immunol"},{"issue":"2","key":"1356_CR30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.molcel.2009.07.031","volume":"36","author":"X Li","year":"2009","unstructured":"Li X, et al. Two mammalian MOF complexes regulate transcription activation by distinct mechanisms. Mol Cell. 2009;36(2):290\u2013301.","journal-title":"Mol Cell"},{"key":"1356_CR31","doi-asserted-by":"crossref","unstructured":"Fiorentino F, et al. First-in-class selective inhibitors of the lysine acetyltransferase KAT8. J Med Chem. 2023.","DOI":"10.1021\/acs.jmedchem.2c01937"},{"issue":"4","key":"1356_CR32","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1084\/jem.20181773","volume":"216","author":"W Huai","year":"2019","unstructured":"Huai W, et al. KAT8 selectively inhibits antiviral immunity by acetylating IRF3. J Exp Med. 2019;216(4):772\u201385.","journal-title":"J Exp Med"},{"issue":"5532","key":"1356_CR33","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1063127","volume":"293","author":"T Jenuwein","year":"2001","unstructured":"Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293(5532):1074\u201380.","journal-title":"Science"},{"issue":"8","key":"1356_CR34","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.molcel.2021.02.012","volume":"81","author":"A Radzisheuskaya","year":"2021","unstructured":"Radzisheuskaya A, et al. Complex-dependent histone acetyltransferase activity of KAT8 determines its role in transcription and cellular homeostasis. Mol Cell. 2021;81(8):1749\u2013e17658.","journal-title":"Mol Cell"},{"issue":"5707","key":"1356_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1105166","volume":"307","author":"ZL Yuan","year":"2005","unstructured":"Yuan ZL, et al. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science. 2005;307(5707):269\u201373.","journal-title":"Science"},{"issue":"4","key":"1356_CR36","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.2018177303182019c","volume":"216","author":"W Huai","year":"2019","unstructured":"Huai W, et al. Correction: KAT8 selectively inhibits antiviral immunity by acetylating IRF3. J Exp Med. 2019;216(4):1001.","journal-title":"J Exp Med"},{"issue":"11","key":"1356_CR37","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1136\/gutjnl-2013-306271","volume":"63","author":"IM Stromnes","year":"2014","unstructured":"Stromnes IM, et al. Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity. Gut. 2014;63(11):1769\u201381.","journal-title":"Gut"},{"issue":"3","key":"1356_CR38","first-page":"727","volume":"10","author":"Y Han","year":"2020","unstructured":"Han Y, Liu D, Li L. PD-1\/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020;10(3):727\u201342.","journal-title":"Am J Cancer Res"},{"issue":"9","key":"1356_CR39","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1172\/JCI80011","volume":"125","author":"L Chen","year":"2015","unstructured":"Chen L, Han X. Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest. 2015;125(9):3384\u201391.","journal-title":"J Clin Invest"},{"issue":"40","key":"1356_CR40","doi-asserted-by":"publisher","first-page":"43005","DOI":"10.18632\/oncotarget.5656","volume":"6","author":"KC Soares","year":"2015","unstructured":"Soares KC, et al. TGF-beta blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner. Oncotarget. 2015;6(40):43005\u201315.","journal-title":"Oncotarget"},{"issue":"1","key":"1356_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CJI.0000000000000062","volume":"38","author":"KC Soares","year":"2015","unstructured":"Soares KC, et al. PD-1\/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors. J Immunother. 2015;38(1):1\u201311.","journal-title":"J Immunother"},{"issue":"4","key":"1356_CR42","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.immuni.2017.03.013","volume":"46","author":"F Arce Vargas","year":"2017","unstructured":"Arce Vargas F, et al. Fc-Optimized Anti-CD25 depletes Tumor-Infiltrating Regulatory T Cells and synergizes with PD-1 blockade to Eradicate established tumors. Immunity. 2017;46(4):577\u201386.","journal-title":"Immunity"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01356-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-025-01356-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01356-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:17:43Z","timestamp":1739978263000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-025-01356-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1186\/s13578-025-01356-3","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"24"}}